Patterns of CMR Measured Longitudinal Strain and Its Association with Late Gadolinium Enhancement in Patients with Cardiac Amyloidosis and Its Mimics

Overview

Journal J Cardiovasc Magn Reson

Publisher Elsevier

Specialties Cardiology & Vascular Diseases
Radiology

Date 2017 Aug 9

PMID 28784140

Citations 52

Authors

Lynne K Williams

Julian F Forero

Zoran B Popovic

Dermot Phelan

Diego Delgado

Harry Rakowski

Bernd J Wintersperger

Paaladinesh Thavendiranathan

Affiliations

Soon will be listed here.

Abstract

Background: Regional variability of longitudinal strain (LS) has been previously described with echocardiography in patients with cardiac amyloidosis (CA), however, the reason for this variability is not completely evident. We sought to describe regional patterns in LS using feature-tracking software applied to cardiovascular magnetic resonance (CMR) cine images in patients with CA, hypertrophic cardiomyopathy (HCM), and Anderson-Fabry's disease (AFD) and to relate these patterns to the distribution of late gadolinium enhancement (LGE).

Methods: Patients with CA (n = 45) were compared to LV mass indexed matched patients with HCM (n = 19) and AFD (n = 19). Peak systolic LS measurements were obtained using Velocity Vector Imaging (VVI) software on CMR cine images. A relative regional LS ratio (RRSR) was calculated as the ratio of the average of the apical segmental LS divided by the sum of the average basal and mid-ventricular segmental LS. LGE was quantified for the basal, mid, and apical segments using a threshold of 5SD above remote myocardium. A regional LGE ratio was calculated similar to RRSR.

Results: Patients with CA had significantly had worse global LS (-15.7 ± 4.6%) than those with HCM (-18.0 ± 4.6%, p = 0.046) and AFD (-21.9 ± 5.1%, p < 0.001). The RRSR was higher in patients with CA (1.00 ± 0.31) than in AFD (0.79 ± 0.24; p = 0.018) but not HCM (0.84 ± 0.32; p = 0.114). In CA, a regional difference in LGE burden was noted, with lower LGE in the apex (31.5 ± 19.1%) compared to the mid (38.2 ± 19.0%) and basal (53.7 ± 22.7%; p < 0.001 for both) segments. The regional LGE ratio was not significantly different between patients with CA (0.33 ± 0.15) and AFD (0.47 ± 0.58; p = 0.14) but lower compared to those with HCM (0.72 ± 0.43; p < 0.0001). LGE percentage showed a significant impact on LS (p < 0.0001), with a 0.9% decrease in absolute LS for every 10% increase in LGE percentage.

Conclusion: The presence of marked "relative apical sparing" of LS along with a significant reduction in global LS seen in patients with CA on CMR cine analysis may provide an additional tool to differentiate CA from other cause of LVH. The concomitant presence of a base to apex gradient in quantitative LGE burden suggests that the regional strain gradient may be at least partially explained by the burden of amyloid deposition and fibrosis.

Citing Articles

Cardiac Functional Assessment by Magnetic Resonance Imaging.

Jiang M, Lu M, Zhao S Cardiol Discov. 2024; 4(4):284-299.

PMID: 39677505 PMC: 11637579. DOI: 10.1097/CD9.0000000000000141.

Clinical and Cardiovascular Magnetic Resonance Imaging Features of Cardiac Amyloidosis.

Tana M, Tana C, Panarese A, Mantini C, Ricci F, Porreca E Rev Cardiovasc Med. 2024; 24(10):291.

PMID: 39077571 PMC: 11273132. DOI: 10.31083/j.rcm2410291.

The value of myocardial contraction fraction and long-axis strain to predict late gadolinium enhancement in multiple myeloma patients with secondary cardiac amyloidosis.

Hu M, Song Y, Yang C, Wang J, Zhu W, Kan A Sci Rep. 2024; 14(1):16832.

PMID: 39039146 PMC: 11263677. DOI: 10.1038/s41598-024-67544-2.

Association between cardiac magnetic resonance ventricular strain and left ventricular thrombus in patients with ST-segment elevation myocardial infarction.

Chen Q, Zhang Z, Chen L, Zhou Z, Lu Y, Zhang C Int J Cardiovasc Imaging. 2024; 40(8):1735-1744.

PMID: 38884697 DOI: 10.1007/s10554-024-03163-2.

The Role of Magnetic Resonance Imaging in Cardiomyopathies in the Light of New Guidelines: A Focus on Tissue Mapping.

Forleo C, Carella M, Basile P, Mandunzio D, Greco G, Napoli G J Clin Med. 2024; 13(9).

PMID: 38731153 PMC: 11084160. DOI: 10.3390/jcm13092621.

References

Phelan D, Collier P, Thavendiranathan P, Popovic Z, Hanna M, Plana J . Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis. Heart. 2012; 98(19):1442-8. DOI: 10.1136/heartjnl-2012-302353. View

Liao R, Jain M, Teller P, Connors L, Ngoy S, Skinner M . Infusion of light chains from patients with cardiac amyloidosis causes diastolic dysfunction in isolated mouse hearts. Circulation. 2001; 104(14):1594-7. View

Maceira A, Joshi J, Prasad S, Moon J, Perugini E, Harding I . Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation. 2005; 111(2):186-93. DOI: 10.1161/01.CIR.0000152819.97857.9D. View

Bergesio F, Ciciani A, Santostefano M, Brugnano R, Manganaro M, Palladini G . Renal involvement in systemic amyloidosis--an Italian retrospective study on epidemiological and clinical data at diagnosis. Nephrol Dial Transplant. 2007; 22(6):1608-18. DOI: 10.1093/ndt/gfm041. View

Fontana M, Pica S, Reant P, Abdel-Gadir A, Treibel T, Banypersad S . Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis. Circulation. 2015; 132(16):1570-9. PMC: 4606985. DOI: 10.1161/CIRCULATIONAHA.115.016567. View

Perugini E, Rapezzi C, Piva T, Leone O, Bacchi-Reggiani L, Riva L . Non-invasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance. Heart. 2005; 92(3):343-9. PMC: 1860803. DOI: 10.1136/hrt.2005.061911. View

Singh A, Steadman C, Khan J, Horsfield M, Bekele S, Nazir S . Intertechnique agreement and interstudy reproducibility of strain and diastolic strain rate at 1.5 and 3 Tesla: a comparison of feature-tracking and tagging in patients with aortic stenosis. J Magn Reson Imaging. 2014; 41(4):1129-37. DOI: 10.1002/jmri.24625. View

Schuster A, Morton G, Hussain S, Jogiya R, Kutty S, Asrress K . The intra-observer reproducibility of cardiovascular magnetic resonance myocardial feature tracking strain assessment is independent of field strength. Eur J Radiol. 2012; 82(2):296-301. DOI: 10.1016/j.ejrad.2012.11.012. View

Vogelsberg H, Mahrholdt H, Deluigi C, Yilmaz A, Kispert E, Greulich S . Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy. J Am Coll Cardiol. 2008; 51(10):1022-30. DOI: 10.1016/j.jacc.2007.10.049. View

10.

Oda S, Utsunomiya D, Nakaura T, Yuki H, Kidoh M, Morita K . Identification and Assessment of Cardiac Amyloidosis by Myocardial Strain Analysis of Cardiac Magnetic Resonance Imaging. Circ J. 2017; 81(7):1014-1021. DOI: 10.1253/circj.CJ-16-1259. View

11.

Williams L, Urbano-Moral J, Rowin E, Jamorski M, Bruchal-Garbicz B, Carasso S . Velocity vector imaging in the measurement of left ventricular myocardial mechanics on cardiac magnetic resonance imaging: correlations with echocardiographically derived strain values. J Am Soc Echocardiogr. 2013; 26(10):1153-1162. DOI: 10.1016/j.echo.2013.06.008. View

12.

Senapati A, Sperry B, Grodin J, Kusunose K, Thavendiranathan P, Jaber W . Prognostic implication of relative regional strain ratio in cardiac amyloidosis. Heart. 2016; 102(10):748-54. DOI: 10.1136/heartjnl-2015-308657. View

13.

Phelan D, Thavendiranathan P, Popovic Z, Collier P, Griffin B, Thomas J . Application of a parametric display of two-dimensional speckle-tracking longitudinal strain to improve the etiologic diagnosis of mild to moderate left ventricular hypertrophy. J Am Soc Echocardiogr. 2014; 27(8):888-95. DOI: 10.1016/j.echo.2014.04.015. View

14.

Maret E, Todt T, Brudin L, Nylander E, Swahn E, Ohlsson J . Functional measurements based on feature tracking of cine magnetic resonance images identify left ventricular segments with myocardial scar. Cardiovasc Ultrasound. 2009; 7:53. PMC: 2785780. DOI: 10.1186/1476-7120-7-53. View

15.

Austin B, Tang W, Rodriguez E, Tan C, Flamm S, Taylor D . Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis. JACC Cardiovasc Imaging. 2010; 2(12):1369-77. DOI: 10.1016/j.jcmg.2009.08.008. View

16.

Ternacle J, Bodez D, Guellich A, Audureau E, Rappeneau S, Lim P . Causes and Consequences of Longitudinal LV Dysfunction Assessed by 2D Strain Echocardiography in Cardiac Amyloidosis. JACC Cardiovasc Imaging. 2016; 9(2):126-38. DOI: 10.1016/j.jcmg.2015.05.014. View

17.

Bennani Smires Y, Victor G, Ribes D, Berry M, Cognet T, Mejean S . Pilot study for left ventricular imaging phenotype of patients over 65 years old with heart failure and preserved ejection fraction: the high prevalence of amyloid cardiomyopathy. Int J Cardiovasc Imaging. 2016; 32(9):1403-1413. DOI: 10.1007/s10554-016-0915-z. View

18.

Gertz M, Comenzo R, Falk R, Fermand J, Hazenberg B, Hawkins P . Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004. Am J Hematol. 2005; 79(4):319-28. DOI: 10.1002/ajh.20381. View

19.

Gersh B, Maron B, Bonow R, Dearani J, Fifer M, Link M . 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the.... J Am Coll Cardiol. 2011; 58(25):e212-60. DOI: 10.1016/j.jacc.2011.06.011. View

20.

Brenner D, Jain M, Pimentel D, Wang B, Connors L, Skinner M . Human amyloidogenic light chains directly impair cardiomyocyte function through an increase in cellular oxidant stress. Circ Res. 2004; 94(8):1008-10. DOI: 10.1161/01.RES.0000126569.75419.74. View